Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program

Raushan T. Kurmasheva, Dias Kurmashev, C. Patrick Reynolds, Min Kang, Jianwrong Wu, Peter J. Houghton, Malcolm A. Smith

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program'. Together they form a unique fingerprint.

Nursing and Health Professions